Remarkably, BRCA1 and BRCA2 preserve genomic stability and inhibit tumorigenesis by fostering DSBs repair via the homologous recombination (HR) system and are often mutated in hereditary breast and ovarian cancers [19]. This evidence concerns the gene BRCA1 and ovarian carcinoma.